People with heart disease who have higher levels of both triglycerides and blood sugar are about 30% more likely to have a heart attack than those with lower levels, even after accounting for other health factors.
Scientific Claim
In adults with chronic stable cardiovascular disease, a higher triglyceride-glucose index (TyG) is associated with a 30% increased risk of myocardial infarction, independent of other risk factors.
Original Statement
“In fully adjusted models, individuals in the highest compared to the lowest quartile of the TyG index were at higher risk for the primary endpoint (HR 1.14; 95% CI 1.05–1.25) and for myocardial infarction (HR 1.30; 95% CI 1.11–1.53).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The abstract uses 'associated with' and reports HR with confidence intervals, appropriate for observational data. No causal verbs are used. Based on abstract only - full methodology not available to verify
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether TyG consistently predicts myocardial infarction across diverse populations with atherosclerotic disease, and whether it adds predictive value beyond traditional risk factors.
Whether TyG consistently predicts myocardial infarction across diverse populations with atherosclerotic disease, and whether it adds predictive value beyond traditional risk factors.
What This Would Prove
Whether TyG consistently predicts myocardial infarction across diverse populations with atherosclerotic disease, and whether it adds predictive value beyond traditional risk factors.
Ideal Study Design
A meta-analysis of 12+ prospective cohorts with individual-level data on TyG and adjudicated myocardial infarction events in patients with established cardiovascular disease, adjusting for LDL, diabetes, smoking, and medications, and calculating pooled HRs with subgroup analyses by age, sex, and statin use.
Limitation: Cannot determine if TyG is a causal driver or merely a marker of metabolic dysfunction.
Prospective Cohort StudyLevel 2bIn EvidenceWhether TyG independently predicts incident myocardial infarction in a well-defined population with stable cardiovascular disease.
Whether TyG independently predicts incident myocardial infarction in a well-defined population with stable cardiovascular disease.
What This Would Prove
Whether TyG independently predicts incident myocardial infarction in a well-defined population with stable cardiovascular disease.
Ideal Study Design
A prospective cohort of 10,000 adults aged 50–80 with documented coronary artery disease, measuring fasting triglycerides and glucose at baseline, following for 7 years, and using Cox models adjusted for LDL, HbA1c, BMI, and medications to estimate TyG’s association with adjudicated myocardial infarction.
Limitation: Observational; cannot rule out residual confounding.
Nested Case-Control StudyLevel 3bWhether TyG levels are elevated prior to myocardial infarction compared to matched controls without events.
Whether TyG levels are elevated prior to myocardial infarction compared to matched controls without events.
What This Would Prove
Whether TyG levels are elevated prior to myocardial infarction compared to matched controls without events.
Ideal Study Design
A nested case-control study within a cohort of 5,000 patients with stable cardiovascular disease, selecting 1,200 cases with incident myocardial infarction and 2,400 matched controls, comparing baseline TyG levels using conditional logistic regression adjusted for LDL and metabolic factors.
Limitation: Cannot establish temporal sequence or generalizability beyond the source cohort.
Evidence from Studies
Supporting (1)
This study looked at people with heart disease and found that those with higher levels of a combo marker (TyG) made from triglycerides and blood sugar were 30% more likely to have a heart attack, even after accounting for other health factors — just like the claim says.